28 September 2022 pharmaceutical Psoriasis

Deucravacitinib FDA approved for plaque psoriasis

31 August 2022 Psoriasis

Pustular psoriasis flares lead to ED admissions

17 August 2022 Psoriasis

Hope for new plaque psoriasis treatment

17 August 2022 Psoriasis

Fortnightly secukinumab better for heavier psoriasis patients

3 August 2022 Drugs Psoriasis

Risankizumab can be used in patients with Crohn’s

20 July 2022 Allergies Atopic Dermatitis patients Psoriasis

Impact of dermatological disease is more than skin deep

20 June 2022 Arthritis Covid-19 Psoriasis psoriatic arthritis

Rituximab and non-white ethnicity linked with worse covid outcomes

8 June 2022 Psoriasis

MS linked to psoriasis risk in family members

25 May 2022 cardiovascular Psoriasis

Biologics improve psoriasis but not CV risk

Sponsored {{ ::category.name }}

Brought to you by {{ ::post.advertiser.name }}